How Has the SAP / Ariba Deal Affected Other Firms’ Stock Prices?

(This article appears in full on Spend Matters PRO, our new subscription service. See here for details on how to subscribe and get even more insight, advice and information about the procurement world!)

It’s been almost two months since the seismic event of the procurement year so far: SAP’s acquisition of Ariba. Whilst many of the questions we raised at the time have yet to be answered, such as the way any product integration might develop or how the two firms’ sales efforts may or may not mesh, we thought it might be an appropriate time to look at the effect on a number of SAP and Ariba’s key competitors.

We commented on Spend Matters UK/Europe about the apparent enthusiastic reaction from a number of competitors. Coupa, for one, seemed genuinely delighted, and not just because of the valuation of Ariba. They, and others such as Proactis, saw this as effectively one less competitor, and perhaps taking Ariba out of contention in certain “anti-SAP” accounts.

But rather than rely on qualitative and subjective comments, we thought we’d look at something a little more factual. While many of the major players in the procurement technology market are privately owned, some have publically quoted stocks and shares. So how has the market evaluated them since the SAP deal? Do investors – who have to put their money where their mouth is – reckon that it has been positive or negative for these other firms?

We’ve taken a look at three firms, listed in three countries, and with three somewhat different competitive positions against SAP and Ariba.

(The three firms we've looked at are Basware, Sci-Quest and Hubwoo - for the full article, see Spend Matters PRO).

Discuss this:

Your email address will not be published. Required fields are marked *